This metabolite includes a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 about 50% on the mum or dad drug. Plasma concentrations of this metabolite are around 40% of those found for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharmacologic outcomes.The suggest profiles in the modify from